NO960724L - Middel for transdermal applisering inneholdende gestodenestere - Google Patents

Middel for transdermal applisering inneholdende gestodenestere

Info

Publication number
NO960724L
NO960724L NO960724A NO960724A NO960724L NO 960724 L NO960724 L NO 960724L NO 960724 A NO960724 A NO 960724A NO 960724 A NO960724 A NO 960724A NO 960724 L NO960724 L NO 960724L
Authority
NO
Norway
Prior art keywords
gestoden
esters
transdermal application
application containing
transdermal
Prior art date
Application number
NO960724A
Other languages
English (en)
Other versions
NO960724D0 (no
Inventor
Ralph Lipp
Henry Laurent
Clemens Gunther
Jutta Riedl
Peter Esperling
Ulrich Tauber
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO960724L publication Critical patent/NO960724L/no
Publication of NO960724D0 publication Critical patent/NO960724D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

Et middel for transdermal appli- sering inneholdende gestodenestere med l til 20 karbonatomer i esterresten, eventuelt i kombinasjon med ett eller to østrogener.
NO960724A 1993-08-26 1996-02-23 Middel for transdermal applisering inneholdende gestodenestere NO960724D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4329242A DE4329242A1 (de) 1993-08-26 1993-08-26 Mittel zur transdermalen Applikation enthaltend Gestodenester
PCT/EP1994/002496 WO1995005827A1 (de) 1993-08-26 1994-07-29 Mittel zur transdermalen applikation enthaltend gestodenester

Publications (2)

Publication Number Publication Date
NO960724L true NO960724L (no) 1996-02-23
NO960724D0 NO960724D0 (no) 1996-02-23

Family

ID=6496410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960724A NO960724D0 (no) 1993-08-26 1996-02-23 Middel for transdermal applisering inneholdende gestodenestere

Country Status (10)

Country Link
US (1) US5858394A (no)
EP (1) EP0715518A1 (no)
JP (1) JPH09504783A (no)
AU (1) AU693802B2 (no)
CA (1) CA2170371A1 (no)
DE (1) DE4329242A1 (no)
FI (1) FI960800L (no)
HU (1) HUT73236A (no)
NO (1) NO960724D0 (no)
WO (1) WO1995005827A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US6540332B2 (en) * 1997-07-15 2003-04-01 Silverbrook Research Pty Ltd Motion transmitting structure for a nozzle arrangement of a printhead chip for an inkjet printhead
US6846496B1 (en) 1999-10-15 2005-01-25 Orion Corporation Treatment of osteoporosis
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
DE10060852A1 (de) * 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
US7330822B1 (en) * 2001-05-29 2008-02-12 Oracle International Corporation Methods and systems for managing hierarchically organized and interdependent tasks and issues
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
US6652020B2 (en) * 2002-04-09 2003-11-25 Norco Industries, Inc. Reinforcing bracket for trailer-frame butt joints
KR100704825B1 (ko) 2003-02-21 2007-04-09 바이엘 쉐링 파마 악티엔게젤샤프트 Ｕｖ 안정성 경피 치료 플라스터
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
JP4965263B2 (ja) * 2003-12-12 2012-07-04 バイエル ファーマ アクチエンゲゼルシャフト 浸透増強剤を必要としないホルモンの経皮送達
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US7468470B2 (en) 2004-03-26 2008-12-23 Schering Ag Medicinal patch that leaves less adhesive residue when removed
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546062A1 (de) * 1975-10-10 1977-04-21 Schering Ag Delta hoch 15 -steroide
US4081537A (en) * 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
EP0394429B1 (de) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend gestoden
NZ240358A (en) * 1990-10-29 1994-09-27 Alza Corp Transdermal contraceptive device comprising (as active agents) an estrogen and a gestodene together with a skin permeation enhancer
JPH0650974A (ja) * 1992-07-29 1994-02-25 Nec Corp 免疫センサシステムおよびこれを用いた免疫測定方法

Also Published As

Publication number Publication date
US5858394A (en) 1999-01-12
DE4329242A1 (de) 1995-03-02
FI960800A0 (fi) 1996-02-22
AU7533694A (en) 1995-03-21
WO1995005827A1 (de) 1995-03-02
JPH09504783A (ja) 1997-05-13
FI960800A7 (fi) 1996-02-22
EP0715518A1 (de) 1996-06-12
HU9503654D0 (en) 1996-02-28
NO960724D0 (no) 1996-02-23
CA2170371A1 (en) 1995-03-02
HUT73236A (en) 1996-07-29
AU693802B2 (en) 1998-07-09
FI960800L (fi) 1996-02-22

Similar Documents

Publication Publication Date Title
NO960724L (no) Middel for transdermal applisering inneholdende gestodenestere
NO950626L (no) Middel for transdermal applikasjon inneholdende 3-ketodesogestrel
ES2183526T3 (es) Derivados de acidos grasos de acidos biliares y derivados del acido biliar.
ES2134937T3 (es) Alquil-glucosido y su uso.
DE59308292D1 (de) Substituierte triole
NL7613708A (nl) Werkwijze voor het polymeriseren van ten minste 3 koolstofatomen bevattende (alpha)-alkenen.
ES2054259T3 (es) Composicion de vitamina b12.
DE69937996D1 (de) Markierte glutamin- und lysinanaloge
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
DE3864531D1 (de) Befestigungseinrichtung fuer verkleidungsplatten.
JPS5425689A (en) Wedge filter unit
ES514044A0 (es) Procedimiento para fabricar lunas de vidrio compuesto.
GB2003724A (en) Brackets
NL7711164A (nl) Werkwijze voor het bereiden van staal met een laag koolstofgehalte.
JPS5419069A (en) Hydraulic driving apparatus
ATE172390T1 (de) Schnellwechselvorrichtung für raupenketten
JPS51119744A (en) Rubber compositions
JPS5367193A (en) Laser beam cover support device
JPS5284836A (en) Device for fitting driving components of automatic door
JPS5430349A (en) Screwing-up structure and two-divided screw bolt
ES2072090T3 (es) Derivados maleimidicos que contienen residuos acrilicos.
JPS5418783A (en) Level display device
JPS51135431A (en) Dc dynamic drive system in a liquid crystal display
JPS5383435A (en) Both-surface display unit
Litvak et al. Transnational corporations in the bauxite-aluminium industry: with special reference to the Caribbean

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application